T
1.38
-0.05 (-3.50%)
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 看跌 | 看跌 |
| Biotechnology (全球的) | 看跌 | 看跌 | |
| 股票 | Tiziana Life Sciences Ltd | 混合的 | 混合的 |
AIStockmoo 评分
-0.8
| 分析师共识 | -2.0 |
| 内部交易活动 | NA |
| 价格波动 | -4.5 |
| 技术平均移动指标 | 1.0 |
| 技术振荡指标 | 2.5 |
| 平均 | -0.75 |
|
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in the developing transformative therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Value |
| 内部持股比例 | 35.56% |
| 机构持股比例 | 0.89% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Zhang Financial Llc | 31 Mar 2025 | 96,260 |
| Kovitz Investment Group Partners, Llc | 31 Mar 2025 | 79,365 |
| Ewa, Llc | 31 Mar 2025 | 47,601 |
| Bison Wealth, Llc | 31 Dec 2024 | 42,795 |
| Bison Wealth, Llc | 31 Mar 2025 | 42,795 |
该时间范围内无数据。
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合